文献速递前列腺癌

PI-RADS类别预测主动监测中前列腺癌进展至不良风险

PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance.
PubMed 文献 · J Urol · 2020-07-27

研究评估主动监测患者基线多参数磁共振PI-RADS类别与进展至Gleason分级分组3级或以上风险的关系。344例有PI-RADS记录,指数病灶PI-RADS 5类者33%(17/51)进展,中位进展时间31个月;PI-RADS类别与进展显著相关(p<0.01),多变量分析仅PI-RADS 5类和PSA密度与进展相关。基线PI-RADS类别有助于风险分层。

要点

  • 指数病灶PI-RADS 5类者33%(17/51)进展至GG3+,中位时间31个月
  • PI-RADS类别与主动监测中进展至GG3+显著相关(p<0.01)
  • 多变量分析中仅PI-RADS 5类和PSA密度与进展独立相关

核心结论

  • 基线多参数磁共振PI-RADS类别可预测主动监测中进展至GG3或以上。

研究设计与样本

  • 2007年7月至2020年1月单机构转诊前列腺癌患者中,持续主动监测且至少记录1次PI-RADS评分者344例。

主要发现

  • 指数病灶PI-RADS 5类者33%(17/51)进展至GG3+,中位进展时间31个月。
  • PI-RADS类别与进展至GG3+显著相关(p<0.01)。
  • 单变量分析中进展相关因素包括指数病灶PI-RADS 5类、PSA密度和最大病灶大小。
  • 多变量分析中仅PI-RADS 5类和PSA密度与进展相关。

临床怎么用

  • 基线PI-RADS类别可结合其他临床数据,辅助泌尿外科医生识别和管理适合主动监测的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We identified baseline imaging and clinical characteristics of patients that may improve risk stratification among patients being evaluated for active surveillance. MATERIALS AND METHODS: From July 2007 to January 2020 patients referred to our institution for prostate cancer were evaluated and those who remained on active surveillance were identified. Men underwent multiparametric magnetic resonance imaging upon entry into our active surveillance protocol during which baseline demographic and imaging data were documented. Patients were then followed and outcomes, specifically progression to Gleason Grade Group (GG)3 or greater disease, were recorded. RESULTS: Of the men placed on active surveillance 344 had at least 1 PI-RADS score documented. For those with an index lesion PI-RADS category of 5, 33% (17/51) had progression to GG3 or greater on active surveillance with a median time to progression of 31 months. When comparing the progression-free survival times and progression rates in each category, PI-RADS category was found to be associated with progression to GG3 or greater on active surveillance (p <0.01). On univariable analysis factors associated with progression included an index lesion PI-RADS category of 5, prostate specific antigen density and the size of the largest lesion. On multivariable analysis only PI-RADS category of 5 and prostate specific antigen density were associated with progression on active surveillance. CONCLUSIONS: PI-RADS lesion categories at baseline multiparametric magnetic resonance imaging during active surveillance enrollment can be used to predict cancer progression to GG3 or greater on active surveillance. This information, along with other clinical data, can better assist urologists in identifying and managing patients appropriate for active surveillance.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Wang AZ, O’Conno LP, Yerram NK, et al. PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance. J Urol. 2020. PMID: 32716685. doi:10.1097/JU.0000000000001307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。